Disorders of cognition

Seminars in Neurology

Volumn 31, Issue 1, 2011, Pages 18-28

  Woodruff, Bryan K ^a  

^a MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Cognition; dementia with Lewy bodies; frontotemporal dementia; mild cognitive impairment

Indexed keywords

CLONAZEPAM; DONEPEZIL; GALANTAMINE; MELATONIN; MEMANTINE; RIVASTIGMINE;

ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; BRAIN DEGENERATION; COGNITION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FRONTOTEMPORAL DEMENTIA; HEADACHE; HUMAN; INSOMNIA; INTERPERSONAL COMMUNICATION; LEG CRAMP; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; MOTOR NEURON DISEASE; MULTIINFARCT DEMENTIA; NAUSEA; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NORMOTENSIVE HYDROCEPHALUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; PSYCHOSIS; SHORT PORTABLE MENTAL STATUS QUESTIONNAIRE; SLEEP DISORDER; SPEECH DISORDER; VIVID DREAM;

COGNITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS;

EID: 79951793685     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0031-1271314     Document Type: Article

References (48)

1. Squire L R., Zola-Morgan S. Memory: brain systems and behavior (Pubitemid 18070242)
2. Mesulam M M. Behavioral neuroanatomy. In: Mesulam M M. ed. Principles of Behavioral and Cognitive Neurology. New York Oxford University Press 2000 1-120
3. Mesulam M M. Primary progressive aphasia. Ann Neurol 2001 49 4 425-432 (Pubitemid 32281326)
4. Mori E, Shimomura T, Fujimori M et al. Visuoperceptual impairment in dementia with Lewy bodies. Arch Neurol 2000 57 4 489-493 (Pubitemid 30212121)
5. Zakzanis K K., Boulos M I. Posterior cortical atrophy. Neurologist 2001 7 6 341-349 (Pubitemid 33140813)
6. Tschampa H J., Neumann M, Zerr I et al. Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2001 71 1 33-39
7. Woodruff B K. Evaluation of rapidly progressive dementia. Semin Neurol 2007 27 4 363-375 (Pubitemid 47340113)
8. Geschwind M D., Shu H, Haman A, Sejvar J J., Miller B L. Rapidly progressive dementia. Ann Neurol 2008 64 1 97-108
9. McKeith I G., Dickson D W., Lowe J et al, Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005 65 12 1863-1872 (Pubitemid 43970103)
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC American Psychiatric Association
11. Petersen R C., Smith G E., Waring S C., Ivnik R J., Tangalos E G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999 56 3 303-308 (Pubitemid 29120227)
12. Ghetti B, Hutton M, Wszolek Z. Frontotemporal dementia and parkinsonism linked to chromosome 17 associated with tau gene mutations (FTDP-17T). In: Dickson D Bergeron C Hauw J-J et al. eds. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Basel ISN Neuropath Press 2003 86-102
13. Marmarou A, Bergsneider M, Klinge P, Relkin N, Black P M. The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalus. Neurosurgery 2005 57 3, Suppl S17-S28 discussion ii-v discussion ii-v
14. Neary D, Snowden J S., Mann D M. Classification and description of frontotemporal dementias. Ann N Y Acad Sci 2000 920 46-51 (Pubitemid 32056551)
15. Miller B L., Cummings J, Mishkin F et al. Emergence of artistic talent in frontotemporal dementia. Neurology 1998 51 4 978-982 (Pubitemid 28473387)
16. Jeste D V., Finkel S I. Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry 2000 8 1 29-34 (Pubitemid 30036838)
17. Mesulam M M. Primary progressive aphasia: a 25-year retrospective. Alzheimer Dis Assoc Disord 2007 21 4 S8-S11
18. Wilson S M., Henry M L., Besbris M et al. Connected speech production in three variants of primary progressive aphasia. Brain 2010 133 Pt 7 2069-2088
19. Mackenzie I R. The neuropathology and clinical phenotype of FTD with progranulin mutations. Acta Neuropathol 2007 114 1 49-54
20. Seelaar H, Schelhaas H J., Azmani A et al. TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations. Brain 2007 130 Pt 5 1375-1385 (Pubitemid 47355944)
21. Boeve B F., Silber M H., Ferman T J. Current management of sleep disturbances in dementia. Curr Neurol Neurosci Rep 2002 2 2 169-177
22. Folstein M F., Folstein S E., McHugh P R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975 12 3 189-198
23. Kokmen E, Smith G E., Petersen R C., Tangalos E, Ivnik R C. The short test of mental status. Correlations with standardized psychometric testing. Arch Neurol 1991 48 7 725-728
24. Nasreddine Z S., Phillips N A., Bdirian V et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005 53 4 695-699 (Pubitemid 41623495)
25. Tariq S H., Tumosa N, Chibnall J T., Perry M H. III, Morley J E. Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disordera pilot study. Am J Geriatr Psychiatry 2006 14 11 900-910 (Pubitemid 44706408)
26. Tang-Wai D F., Knopman D S., Geda Y E. et al. Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment. Arch Neurol 2003 60 12 1777-1781 (Pubitemid 37521636)
27. Smith T, Gildeh N, Holmes C. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatry 2007 52 5 329-332 (Pubitemid 46743462)
28. Lucas J A., Ivnik R J., Willis F B. et al. Mayo's Older African Americans Normative Studies: normative data for commonly used clinical neuropsychological measures. Clin Neuropsychol 2005 19 2 162-183 (Pubitemid 40805845)
29. Judd T, Capetillo D, Carrin-Baralt J et al, NAN Policy and Planning Committee. Professional considerations for improving the neuropsychological evaluation of Hispanics: a National Academy of Neuropsychology education paper. Arch Clin Neuropsychol 2009 24 2 127-135
30. Knopman D S., DeKosky S T., Cummings J L. et al, Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: diagnosis of dementia (an evidence-based review). Neurology 2001 56 9 1143-1153
31. Jack C R. Jr, Petersen R C., Xu Y C. et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999 52 7 1397-1403 (Pubitemid 29190530)
32. O'Brien J T. Role of imaging techniques in the diagnosis of dementia. Br J Radiol 2007 80 Spec No 2 S71-S77 (Pubitemid 351799333)
33. Cambier D M., Kantarci K, Worrell G A., Westmoreland B F., Aksamit A J. Lateralized and focal clinical, EEG, and FLAIR MRI abnormalities in Creutzfeldt-Jakob disease. Clin Neurophysiol 2003 114 9 1724-1728 (Pubitemid 37025806)
34. Morris R G., Salmon D P. The centennial of Alzheimer's disease and the publication of Uber eine eigenartige Erkankung der Hirnrinde by Alis Alzheimer. Cortex 2007 43 7 821-825 (Pubitemid 47517035)
35. Rogers S L., Farlow M R., Doody R S., Mohs R, Friedhoff L T., Donepezil Study Group. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 1998 50 1 136-145
36. Doody R S., Stevens J C., Beck C et al, Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: management of dementia (an evidence-based review). Neurology 2001 56 9 1154-1166
37. Reisberg B, Doody R, Stffler A, Schmitt F, Ferris S, Mbius H J., Memantine Study Group. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 2003 348 14 1333-1341 (Pubitemid 36384100)
38. Bordier P, Garrigue S, Lanusse S et al. Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer's disease. CNS Drugs 2006 20 5 411-417 (Pubitemid 43763740)
39. Winblad B, Kilander L, Eriksson S et al, Severe Alzheimer's Disease Study Group. Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study. Lancet 2006 367 9516 1057-1065
40. Wilkinson D, Doody R, Helme R et al, Donepezil 308 Study Group. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology 2003 61 4 479-486 (Pubitemid 37025364)
41. Emre M, Aarsland D, Albanese A et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 2004 351 24 2509-2518 (Pubitemid 39603164)
42. Henderson S T., Vogel J L., Barr L J., Garvin F, Jones J J., Costantini L C. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond) 2009 6 31 31
43. Schneider L S., Dagerman K S., Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005 294 15 1934-1943 (Pubitemid 41464695)
44. Kunz D, Mahlberg R. A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. J Sleep Res 2010 19 4 591-596
45. Ringman J M., Simmons J H. Treatment of REM sleep behavior disorder with donepezil: a report of three cases. Neurology 2000 55 6 870-871
46. Yeh S B., Yeh P Y., Schenck C H. Rivastigmine-induced REM sleep behavior disorder (RBD) in a 88-year-old man with Alzheimer's disease. J Clin Sleep Med 2010 6 2 192-195
47. Dubinsky R M., Stein A C., Lyons K. Practice parameter: risk of driving and Alzheimer's disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2000 54 12 2205-2211 (Pubitemid 30416267)
48. Iverson D J., Gronseth G S., Reger M A., Classen S, Dubinsky R M., Rizzo M, Quality Standards Subcomittee of the American Academy of Neurology. Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2010 74 16 1316-1324